| 000 | 01594 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515032828.0 | ||
| 264 | 0 | _c20060907 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-05-4563 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInoue, Satoshi | |
| 245 | 0 | 0 |
_aInhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. _h[electronic resource] |
| 260 |
_bCancer research _cJul 2006 |
||
| 300 |
_a6785-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xpharmacology |
| 650 | 0 | 4 | _aHistone Deacetylase 1 |
| 650 | 0 | 4 | _aHistone Deacetylase 2 |
| 650 | 0 | 4 | _aHistone Deacetylase Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
| 650 | 0 | 4 | _aJurkat Cells |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xpharmacology |
| 650 | 0 | 4 |
_aRepressor Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTNF-Related Apoptosis-Inducing Ligand |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 650 | 0 | 4 | _aU937 Cells |
| 700 | 1 | _aMai, Antonello | |
| 700 | 1 | _aDyer, Martin J S | |
| 700 | 1 | _aCohen, Gerald M | |
| 773 | 0 |
_tCancer research _gvol. 66 _gno. 13 _gp. 6785-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-05-4563 _zAvailable from publisher's website |
| 999 |
_c16410910 _d16410910 |
||